Jane Street’s RxSight RXST Stock Holding History

Jane Street’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,200	Closed	-$271K	–	12201
2025 Q3	$271K	Buy	30,200 +10,300	+52%	+$90.4K	﹤0.01%	9099
2025 Q2	$259K	Buy	+19,900	New	+$299K	﹤0.01%	8113

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street's RXST Position: Q2 2026 in Review

Jane Street sold out of RxSight (RXST) in Q2 2026, closing a stake of 223,904 shares — an estimated $1.38M sold.

Jane Street first reported a position in RXST in Q1 2023 and held it in 12 quarters. The position peaked at $3.11M in Q2 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Jane Street reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
Jane Street sold 223,904 RxSight shares in Q2 2026, an estimated $1.38M.
Jane Street first reported a position in RxSight in Q1 2023 and held it in 12 quarters.
Jane Street's RxSight position peaked at $3.11M in Q2 2024.
152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.